Spironolactone ameliorates the cardiovascular toxicity induced by concomitant trastuzumab and thoracic radiotherapy


Yavas G., Celik E., Yavas C., Elsurer C., Afsar R.

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, cilt.22, ss.295-302, 2017 (ESCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 22 Konu: 4
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.rpor.2017.01.004
  • Dergi Adı: REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY
  • Sayfa Sayıları: ss.295-302

Özet

Aim: We aimed to evaluate impact of spironolactone (S) on cardiovascular toxicity of concomitant use of radiotherapy (RT) and trastuzumab (T).